Dianthus Therapeutics grants new hires stock options for 106,000 shares at $88.32 each

• Dianthus Therapeutics granted inducement equity awards on Oct. 1, 2026 to six newly hired non-executive employees.
• Non-qualified stock options cover 106,000 shares with a 10-year term.
• Exercise price set at $88.32 per share.
• Vesting schedule: 25% after one year, then monthly installments over the next 36 months.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dianthus Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610011700PRIMZONEFULLFEED9838255) on October 01, 2026, and is solely responsible for the information contained therein.